Get started
Lets discuss the latest clinical trial report Lund Sweden, July 31, 2018 –Active Biotech (NASDAQ OMX NORDIC: ACTI) today provided an update regarding the clinical development of laquinimod by Teva Pharmaceutical Industries Ltd. The Phase 2 LEGATO-HD trial evaluating the safety and efficacy of laquinimod as a treatment in Huntington’s disease (HD) did not meet its primary endpoint of change from baseline after 12 months of treatment, as measured by the Unified Huntington’s Disease Rating Scale – Total Motor Score (UHDRS-TMS). The study’s secondary endpoint, reduction of brain atrophy (measured by caudate volume) was met. The safety results were similar to the expected event profile in this patient population. prevalence Huntington disease= 2-10 / 100.000 Discussion: To date there is no cure for this degenerative disease, as published to the press the clinical trial currently at phase 2 did not meet the endpoint of changing the baseline for motor Score, this explains the profound falling of the price at that time (from 7 to 3 SEK). Now an important thought on this price action is the following. They managed to reduce the brain atrophy (i.e. the a decrements in the neural cellsize, or soma), which is in fact a much more reliable proof of work measurement than coining scores for the patients ability to control his/her movements , and in simple words means that the patient won't cure from this disease but he will deteriorate more slowly. Which is.... Progress right? En plus, the side effects are as expected. So, just from the research point of view this is not bad new, quite the contrary. For the price itself I believe it has a very tempting digit. Happy trading
OMXSTO:ACTI
by joachim.snellings
Oscar PropertiesOscar Properties OP - Swedish Luxury Apartment Developer In this series of Swedish Real Estate charts we take a look at Oscar Properties - oscarproperties.com Oscar Properties are a Stockholm based residential developer specialising in high end residential projects. In 2014 they entered the NASDAQ and subsequently had a dynamic rise to a high in march 2017 at which point a major sell off - possibly post market due to the price gap between trading hours occurred. Price thereafter rolled over in a major sell off. Since a large sell off at the hight of price OP have gradually sold off and appear to have bottomed out - however this process should also be read in conjunction with the HOX OMX Valueguard Stockholm Apartments - What we see here is stock price directly related to a housing market bubble and subsequent warning in 2017 that a major price correction in residential prices was on the cards as investors fled the market. Stock is currently trading below it's entry price in 2014 and a recent rally appears to have been quickly sold off and now returns under the 50MA which is also caught under the 200MA after a death cross was formed in July 2017. Either there is a solid bottom forming for a potential rally in the coming years or Oscar Property stock is in danger of falling lower - a break below 22.0 would signal immanent danger for the company. However a basing pattern followed by a revival in the housing market may see their stock lifted up - the warning for potential investors is that any rally may get sold off as retail investors caught in the price action from July 2017 onwards and who did not get out during a 5 wave capitulation stage will be keen to sell directly into it. Prognosis - Very Bearish - however given that major projects are near completion any news of takeover or external intervention may see stocks rise. Therefore if one were to take a risk (this is not financial advise and is speculated for educational purposes) a buy may be placed at a break out level above the previous rally with a tight stop or small amounts of stock could be purchased with a stop under the low of the last phase in case of a breakout. A recent warning is that it appears that a negative coil is being formed and this is a bearish sign that stocks may drop again. More to follow on charts related to the Swedish Housing Market -
O
by J00Z1
1
GARO not able to push up above 190, will it test support line?My first published idea. GARO has been in a downtrend since it's peak as shown in this chart, it has tried to break the resistance of 190 numerous times however has only managed staying above it for a few days at best. I'm a new trader, GARO was one of my first purchases, on Jan 10th I bought in at 181,2 which looking back I shouldn't have, on April 11th the stock shot up almost 6% on no news whatsoever touching 190, I decided to sell off my shares the following morning at 189. I want to enter but at a better position this time, I drew the support line and will be looking for it to bounce off of that line once again, that will be where I want to buy in, I'm guessing 170-175, and after that I will see if we can break the massive 190 resistance or not. GARO has tried to break the 190 resistance 6 Days in a row now, I am fairly new to trading but I figure the more days that go bye without it being able to break through the less likely it is that it will, feels like there won't be enough power left to keep buying or am I wrong? That is why I believe it will once again drop and come close to the support line within the next couple of days, the pattern is getting tighter and I'll be looking for a break after that. If it has any relevance the company is swedish and the currency is Swedish Kronor (SEK). Thank you for any input.
OMXSTO:GAROLong
by leinad91